Orcid Publication

Detalle de: Bovine Intelectin 2 Expression as a Biomarker of Paratuberculosis Disease Progression

Title Bovine Intelectin 2 Expression as a Biomarker of Paratuberculosis Disease Progression
Abstract

Paratuberculosis (PTB), a chronic granulomatous enteritis caused by Mycobacterium avium subsp. paratuberculosis (MAP), is responsible for important economic losses in the dairy industry. Our previous RNA-sequencing (RNA-Seq) analysis showed that bovine intelectin 2 (ITLN2) precursor gene was overexpressed in ileocecal valve (ICV) samples of animals with focal (log2 fold-change = 10.6) and diffuse (log2 fold-change = 6.8) PTB-associated lesions compared to animals without lesions. This study analyzes the potential use of ITLN2, a protein that has been described as fundamental in the innate immune response to infections, as a biomarker of MAP infection. The presence of ITLN2 was investigated by quantitative immunohistochemical analysis of ICV samples of 20 Holstein Friesian cows showing focal (n = 5), multifocal (n = 5), diffuse (n = 5) and no histological lesions (n = 5). Significant differences were observed in the mean number of ITLN2 immunostained goblet and Paneth cells between the three histopathological types and the control. The number of immunolabelled cells was higher in the focal histopathological type (116.9 ± 113.9) followed by the multifocal (108.7 ± 140.5), diffuse (76.5 ± 97.8) and control types (41.0 ± 81.3). These results validate ITLN2 as a post-mortem biomarker of disease progression.

Apa Reference Blanco Vázquez, C., Balseiro, A., Alonso-Hearn, M., Juste, R.A., Iglesias, N., Canive, M. & Casais, R. (2021). Bovine Intelectin 2 Expression as a Biomarker of Paratuberculosis Disease Progression. Animals, 11(5), 1370. 10.3390/ani11051370
Doi 10.3390/ani11051370
Publication Date 12 May 2021
Publication Type Article
Ontology Transcriptomics, RNA Sequencing (RNA-seq)
Researchers Marta Alonso Fernández-Pacheco
Research Groups
Tools

Suggest changes

Publications are synced automatically from ORCID, so they can't be edited here directly. Spotted something wrong? Let us know below and we'll take care of it.

← Return to Home